- Home
- LNTH vs LW Comparison
LNTH vs LW Comparison
Compare LNTH & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | LW |
|---|---|---|
| Founded | 1956 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 8.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | LW |
|---|---|---|
| Price | $65.90 | $45.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $78.00 | $66.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 11-06-2025 | 12-19-2025 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 2.08 |
| Revenue | $1,525,933,000.00 | ★ $6,456,500,000.00 |
| Revenue This Year | $0.01 | $4.12 |
| Revenue Next Year | $1.24 | N/A |
| P/E Ratio | ★ $27.10 | $28.56 |
| Revenue Growth | ★ 1.95 | 0.00 |
| 52 Week Low | $47.25 | $47.87 |
| 52 Week High | $111.29 | $81.75 |
Technical Indicators
Market Signals| Indicator | LNTH | LW |
|---|---|---|
| Relative Strength Index (RSI) | 67.49 | 17.52 |
| Support Level | $64.13 | $59.20 |
| Resistance Level | $67.01 | $60.51 |
| Average True Range (ATR) | 2.14 | 1.74 |
| MACD | 0.33 | -0.79 |
| Stochastic Oscillator | 85.42 | 3.62 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.